42nd Global Summit on Biomedical & Cancer Research
  • Follow

SciTech Biomed-Cancer 2023

42nd Global Summit on Biomedical & Cancer Research


June 06-07, 2023

Register Now

42nd Global Summit on Biomedical & Cancer Research

After a successful completion of 37th International Conference on Biomedical & Cancer Research during February 16-17, 2023, we are initiating SciTech Biomed-Cancer 2023 (42nd Global Summit on Biomedical & Cancer Research) is a 2 days seminar scheduled on June 06-07, 2023. It could be a great stage for all academicians, researchers, scientists, students, faculty members, healthcare executives, doctors, industrialists, entrepreneurs to share their contemplation among all the participants. The interested speakers are requested to submit their abstract and video of their research or Webposter.. Exhibitors are invited to promote their healthcare products at our conference website.

Biomedical science is a field of science mainly deals with Life sciences, Physiological sciences and Bioengineering. It covers vast range of topics like  Human Anatomy and Physiology, Cell biology, Genetics, life science, Biomedical Engineering, Bioinformatics, Biotechnology, Medical and Clinical research, Pharmacology, Immunology,  Biochemistry etc. Biomedical research focuses on finding cures and preventative measures for illnesses that sicken and kill both humans and animals. Biomedical researchers examine biological processes and illnesses using biotechnology techniques with the ultimate objective of creating efficient therapies and cures. Clinical trials are staged investigations utilising human subjects that are used for the majority of biomedical research. They are intended to address safety and efficacy concerns about biologics, devices, medications, new therapies, or novel ways of administering existing treatments. Trials are frequently started in small groups before being expanded once safety and effectiveness are shown.

Cancer is a complicated and varied illness that develops when normal cellular processes are interfered by genetic or epigenetic alterations. In order to support the diverse and dynamic needs of cancer research, from the development of novel therapeutics to uncovering fresh insights into cancer pathogenesis, Cell Signaling Technology (CST) has substantial expertise backed by an extensive catalogue of exceptionally reliable, sensitive and validated products. Cancer research has advanced from an empiric to a mechanistic approach which has greatly advanced translational and clinical research, enhanced medical practise and improved patient outcomes. The mechanisms through which genetic, genomic, epigenetic and immunobiologic modifications are crucial to the development of cancer have helped to define cancer types and vulnerabilities for targeted therapy more precisely.

Discussions on: 
  • Cancer Detection, Diagnosis and Therapy
  • Latest Technologies in Biomedical Analysis
  • Types of Cancer and their Immunotherapy
  • Advances in Cancer Research and Treatment
  • Nanotechnology in Cancer Therapeutics
  • Biomedical & Health Informatics
  • Biomedical Robotics and Mechanics
  • Future of Biomedical Engineering
  • Biomechanics & Biomedical Applications
  • Nanotechnology in Cancer Therapeutics
  • Cancer Immunology and Pathology
  • Integrative Computational Cancer Biology
  • Breast Cancer Therapy
  • Cancer Management and Research
  • Cancer and its Relevance with other Diseases
  • Gut Microbiota Implications in Cancer
  • COVID-19 and its Impact on Cancer
  • Cancer Screening and Prevention
  • Melanoma, Oral and Oropharyngeal Cancer
  • Biomarkers of Cancer Stem Cells
  • Biomedical Advancements in Cancer
  • Genetics of Breast Cancer, Therapeutics & New Methods
  • Types of Breast Cancer
  • Breast Cancer Immunotherapy & Radiation Therapy
  • Screening & Diagnosis for Breast Cancer
  • Complementary and Alternative Cancer Treatments
  • Clinical Research and Clinical Trials of Cancer
  • Novel Approaches and Pharmaceutical Drugs for Cancer Therapy
  • Pharmacovigilance and Drug Safety
  • Pediatric Hematology & Oncology Nursing
  • Bionanomaterial and Nanotechnology
  • Role of Bioinformatics
  • Modern advancements in Oncology Diagnostics Technologies
  • Biotechnology in Healthcare
  • Human Anatomy and Physiology
  • Novel Anti-cancer Agents
  • Challenges in Pathology



Accepted Abstracts

Associated Journals


Abstract Due Date: June 02, 2023

Registration Closes: June 05, 2023


Register your interest to keep up to date with the latest information.